LY 201409
LY 201409 is an anticonvulsant compound that is an analog of LY-201116 with improved metabolic activity. LY 201409 antagonizes maximal electroconvulsive-induced seizures, has mixed effects on seizures induced by multiple chemoconvulsants, and affects behavior and sleep in mice[1].
Product Specifications
CAS Number
109306-94-7
UNSPSC
12352005
Target
Drug Derivative
Type
Reference compound
Related Pathways
Others
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/ly-201409.html
Smiles
O=C(C1=CC(C)=C(N)C(C)=C1)NC2=C(C)C=CC=C2C
Molecular Formula
C17H20N2O
Molecular Weight
268.35
References & Citations
[1]Robertson DW, et al. Pharmacology of LY201409, a potent benzamide anticonvulsant. Epilepsia. 1988 Nov-Dec;29 (6) :760-9.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC881037-500 1x 500 µL
CD44 Standard (DF1485), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880304-500 1x 500 µL
CD106 / VCAM1 (B-K9), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740158-100 1x 100 µL
Cytokeratin 17 (E3), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680925-500 1x 500 µL
Mucin 1 / EMA / Episialin / CD227 (139H2), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680810-100 1x 100 µL
AFP (Alpha Fetoprotein) (C2 + C3 + MBS-12), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740755-100 1x 100 µL
Human Kappa Light Chain (HP6053 + L1C1), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details